0.9% Sodium Chloride, JNJ-78901563 clinical trials

Randomized, Double-blind, Placebo-controlled, Multicenter Phase 3 Study to Assess the Efficacy, Safety And Immunogenicity of Vaccination With ExPEC9V in the Prevention of Invasive Extraintestinal Pathogenic Escherichia coli Disease in Adults Aged 60 Years And Older with a History of Urinary Tract Infection in the Past 2 Years

This study is testing a new vaccine to prevent serious infections caused by certain types of E. coli bacteria in adults aged 60 and over who have had urinary tract infections. It compares the vaccine to a dummy treatment.